With nearly 30 years’ experience in pharmaceutical portfolio management, Jenny has a proven track record covering all aspects of a product’s lifecycle, including from early R&D to loss of exclusivity. She is a skilled coach and authentic leader, dedicated to unlocking the potential in organizations and team members.
In her current role as Global Leader of Pfizer’s Biosimilars business, Jenny leads global strategy, alliance management, M&A integration, market development and commercialization of biosimilars.
Prior to this role, Jenny was General Manager for Pfizer’s Established Products business unit in Australia and New Zealand, managing a portfolio of more than 150 branded and generic medicines used in general practice and hospital settings.
Additional career highlights include successfully managing and growing the Norvasc® brand and leading the global team responsible for developing the commercialization strategy for Chantix®. Jenny’s ability to incorporate consumer insights into marketing strategies contributed to a leadership role in establishing the Patient and Marketing Centers of Expertise.
Throughout her career, she has demonstrated a passion for business growth and team leadership, with exemplary abilities in change management and cross-functional partnerships. In 2004, Jenny was the recipient of the Healthcare Business Women’s Association Rising Star Award, reflecting her strengths and achievements in healthcare.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October